 |
 |
 |
|
A NEW NON-INVASIVE DIAGNOSTIC SCORE TO MONITOR CHANGE IN DISEASE ACTIVITY
AND PREDICT FIBROSIS EVOLUTION IN PATIENT WITH NASH
|
|
|
Reported by Jules Levin
EASL 2017 April 19-23 Amsterdam Netherlands
Stephen A Harrison1, Emilie Praca2, John Brozek2, Genevieve Cordonnier2, Fouad Ben Sudrick2, Alice Roudot2, Pierre Bedossa3, Vlad Ratziu4, Bart Staels5, Dean W Hum2, Sophie Megnien2, Pierre Chaumat2, Remy Hanf2, Arun J Sanyal6
1Pinnacle Clinical Research, San Antonio, TX, United States; 2GENFIT,Loos, France; 3Department of Pathology, Hopital Beaujon, Paris, France; 4Hopital Pitié Salpetrière, Paris, France; 5Institut Pasteur de Lille, Lille, France; 6Virginia Commonwealth University, Richmond, VA, United States





|
|
|
 |
 |
|
|